Newmark believes the life sciences sector has turned a corner, noting a surge in IPOs—18 in the first half of this year—and $500 billion in biomanufacturing commitments over the past year. The XBI biotech ETF rose 90.8% year-over-year as of June, and 4.3 million square feet was leased in major life sciences markets. However, challenges [...]